Affiliate Marketing in HealthTech & Telemedicine: Compliance, Privacy & Monetisation
By Rachel Morgan, Affiliate Marketing Expert at iRev | 8 min read
Content:
- Regulatory Landscape in HealthTech Affiliate Marketing
- Privacy & Data Protection Requirements
- Ethical Considerations in Promoting HealthTech & Telemedicine
- Building a Compliant Affiliate Program
- Effective Monetisation Models in HealthTech Affiliate Marketing
- Choosing the Right Affiliate Partners
- Analytics & Performance Optimisation
- Real FDA/FTC Enforcement Examples
- Conclusion
- Frequently Asked Questions (FAQ)
HealthTech and telemedicine industries have undergone accelerated growth due to expanded digital healthcare adoption and increased demand for remote patient services. This transformation has opened opportunities for affiliate marketing as a strategic acquisition channel. Brands rely on partnerships with publishers, medical professionals, and specialised platforms to scale user acquisition ethically and efficiently. Unlike traditional sectors, HealthTech requires a more rigorous operational framework, shaped by data-sensitive environments and regulatory demands.
Affiliate marketing in healthcare differs significantly from mainstream verticals. Affiliates interact with audiences seeking medical guidance, diagnostic tools, or remote consultations. The stakes are therefore high, as inaccurate claims or non-compliant practices can trigger legal violations. For companies promoting HealthTech affiliate marketing, the focus must be on transparency, regulatory adherence, and evidence-based communication.
| HealthTech affiliate marketing in numbers | |||
|---|---|---|---|
| $141B | 17.5% | 33.4% | $380B |
| Global telemedicine market, 2024 (Grand View Research) | Projected CAGR, 2025–2030 (Grand View Research) | North America share of global telemedicine revenue, 2024 | Projected market size by 2030 (Grand View Research) |
Regulatory Landscape in HealthTech Affiliate Marketing
The regulatory environment governing HealthTech and telemedicine spans multiple jurisdictions, including HIPAA in the United States, GDPR in the European Union, and country-specific healthcare frameworks. These regulations define strict standards for handling patient information, consent practices, and promotional claims. Any affiliate activity must align with these laws, even when affiliates do not directly collect health data themselves.
Compliance requirements extend to content accuracy, tracking methods, and data storage procedures. Advertisers must provide affiliates with detailed marketing guidelines to prevent the distribution of misleading or non-validated statements. Telemedicine providers fall under additional scrutiny as they deliver medical consultations, diagnostics, and therapeutic recommendations remotely. As a result, both brands and affiliates share responsibility for maintaining lawful promotional standards.
| Country | Primary regulator(s) | Key law / framework | Telemedicine status | Affiliate restrictions |
|---|---|---|---|---|
| USA | FDA, FTC, HHS (OCR) | HIPAA, FTC Act §5, FDA FD&C Act | Permitted; state-by-state physician licensing | PHI handling needs BAA; FTC Endorsement Guides (2023 update) require clear, conspicuous disclosure |
| EU (general) | EDPB + national DPAs, EMA | GDPR, MDR (EU 2017/745) | Permitted; member-state rules vary | Explicit consent for health data; medical-device claims regulated; cross-border ad rules apply |
| UK | ICO, MHRA, ASA, CMA | UK GDPR, Data Protection Act 2018, CAP Code | Permitted; CQC registration for clinical services | ASA prohibits health claims not authorised by MHRA; influencer disclosure mandatory |
| Canada | OPC, Health Canada | PIPEDA, Food and Drugs Act | Permitted; provincial licensing | Prescription-drug ads to consumers restricted; Health Canada pre-approval for some claims |
| Australia | OAIC, TGA | Privacy Act 1988, Therapeutic Goods Act | Permitted; Medicare telehealth items defined | TGA Advertising Code prohibits testimonials for medicines; strict celebrity-endorsement rules |
| Brazil | ANPD, ANVISA, CFM | LGPD, RDC 96/2008 | Permitted (CFM Resolution 2.314/2022) | ANVISA prohibits prescription-drug advertising to public; LGPD requires explicit consent |
| Germany | BfArM, national DPAs | GDPR + DiGA framework (DVG) | Permitted; reimbursed DiGA apps via BfArM directory | HWG (Heilmittelwerbegesetz) limits health-product advertising; restrictions on remote drug sales |
Three rules every US affiliate marketer must understand:
FTC Endorsement Guides (revised June 2023). Every endorsement, testimonial, or influencer post must clearly and conspicuously disclose any material connection (payment, free product, commission). Disclosures must be in the same medium as the endorsement — a YouTube disclosure cannot live only in the video description. Both the advertiser and the endorser can be held liable.
FDA rules on off-label promotion. Promoting a prescription drug for any use not in its FDA-approved label is prohibited — even if peer-reviewed evidence supports the use. Affiliates pushing GLP-1 drugs for cosmetic weight loss, for instance, must stick strictly to the label’s indication and approved patient population.
General wellness vs. medical device. A “sleep tracker” marketed for relaxation and general wellness is largely unregulated. A “sleep apnea diagnostic” is a Class II medical device requiring FDA clearance, and affiliate claims about it are subject to FDA enforcement. The line is the intended use you advertise — if your copy says “diagnose,” “treat,” “cure,” or “prevent,” you have crossed into device territory.
Privacy & Data Protection Requirements
Privacy plays a critical role in healthcare compliance marketing, as affiliate funnels frequently involve user interactions with sensitive medical information. Tracking systems must follow consent-based principles, enabling users to understand what data is collected and how it is processed. Affiliates working with GDPR health data marketing need mechanisms that support opt-in consent, anonymisation, and data minimisation.
Secure workflows should eliminate unnecessary exposure of personal health information. This includes encrypted communication channels, tokenised identifiers, and cookie-less attribution methods. Below are essential privacy practices for HealthTech affiliate programmes:
- Use privacy-centric analytics tools that comply with HIPAA and GDPR standards
- Apply granular consent forms and transparent cookie notices
- Implement strict data access segmentation to reduce internal risks
Failure to manage these aspects can result in heavy penalties and reputational damage.
The compliant healthcare affiliate stack typically combines four layers:
HIPAA-compliant analytics. Freshpaint (purpose-built for healthcare), Avo with PHI-safe schemas, Heap with signed BAA, PostHog (self-hosted on infrastructure you control). Avoid standard Google Analytics on pages handling PHI — Google does not sign a BAA for GA.
Consent Management Platform (CMP). OneTrust, Cookiebot, Usercentrics, Iubenda. All support Google Consent Mode v2 and IAB TCF v2.2, which are required for GDPR-compliant programmatic and remarketing flows.
Server-side tracking. Stape, JENTIS, Google Tag Manager Server-Side. Server-side containers move event data out of the browser, allow PHI stripping before sending to vendors, and survive cookieless and ITP environments.
Hashed identifiers and S2S postbacks. SHA-256 hashed email for cross-platform matching, LiveRamp’s RampID for identity resolution, S2S postbacks to affiliate networks (eliminates client-side fraud and PHI leaks). Most affiliate platforms — including IREV — support S2S out of the box.
Business Associate Agreement (BAA). A BAA is a HIPAA-required contract between a covered entity (telehealth provider, hospital) and any vendor that handles Protected Health Information (PHI) on its behalf — including analytics platforms, ad servers, affiliate networks, and CRM tools. The BAA makes the vendor legally accountable for HIPAA breaches, defines permitted PHI uses, and establishes breach notification obligations. Without a signed BAA, sharing PHI with that vendor is a HIPAA violation, regardless of intent. For affiliate programs: if your tracking partner sees any patient-identifying information — email, phone, IP plus health context — you need a BAA with them.
Ethical Considerations in Promoting HealthTech & Telemedicine
Ethical marketing is fundamental in healthcare, where users often rely on content to make medically significant decisions. Affiliates must avoid exaggerated outcomes, unsupported claims, or misleading endorsements. All statements should be backed by clinical data, validated product specifications, and professional guidance from qualified healthcare experts.
Affiliates promoting telemedicine platforms need to maintain objectivity, especially when describing remote diagnostic capabilities or treatment recommendations. The use of healthcare influencer marketing requires additional oversight to ensure influencers disclose partnerships clearly and avoid presenting personal experiences as universal medical advice. Ethical frameworks reinforce long-term trust between users, brands, and regulators.
Key ethical priorities include:
- Accuracy and evidence-based descriptions
- Transparent partner disclosures
- No promotion of unapproved treatments or medical devices
These principles allow brands to scale responsibly while preserving patient safety.
| ✅ Generally allowed (structure/function or wellness) | ❌ Generally not allowed (drug/disease claim) |
|---|---|
| “Supports healthy sleep patterns” | “Cures insomnia” |
| “May help maintain blood-sugar levels already within a normal range” | “Treats Type 2 diabetes” |
| “Designed for adults exploring weight management as part of a broader lifestyle plan” | “Guaranteed 15 lbs lost in 30 days” |
| “Connect with a licensed provider who can discuss whether [medication category] is appropriate for you” | “Get Ozempic prescribed in 5 minutes” |
| “Helps support cardiovascular health alongside diet and exercise” | “Prevents heart attacks” |
| “For general wellness and stress management” | “Treats clinical depression and anxiety disorder” |
| “Independent research participants reported improved sleep quality, see study link” | “9 out of 10 users cured their sleep problems” (without substantiation) |
Building a Compliant Affiliate Program
A compliant affiliate programme requires structured onboarding, consistent monitoring, and detailed documentation. Brands must supply affiliates with pre-approved marketing materials, compliant messaging templates, and guidance on regulatory constraints. This reduces the risk of unauthorised claims appearing across advertising channels.
An effective compliance framework includes:
- Legal agreements outlining banned phrases, claim usage rules, and data handling requirements
- Periodic audits of affiliate content across blogs, social feeds, and landing pages
- Automated monitoring tools that identify deviations from approved messaging
The table below summarises core compliance components:
| Compliance Area | Description |
|---|---|
| Content Accuracy | Ensures all affiliate content aligns with validated clinical facts |
| Data Protection | Enforces secure handling of user information |
| Tracking Compliance | Uses consent-driven, privacy-friendly attribution |
| Enforcement | Applies penalties or suspensions for violations |
Compliant programme architecture protects both the brand and the end user while enabling scalable growth.
HealthTech affiliate program — 10-step launch checklist
- Legal review of the vertical: confirm which laws apply (HIPAA/GDPR/national medical-ad rules) for every target market.
- Define what data your program will handle, and classify it (PHI vs. non-PHI). PHI changes everything downstream.
- Sign BAAs with every vendor that touches PHI: analytics, CMP, affiliate platform, CRM, email, ad servers.
- Implement consent management (CMP) with GDPR-grade granularity and Google Consent Mode v2.
- Set up server-side tracking with hashed identifiers and PHI-stripping rules; document the data flow.
- Draft a healthcare-specific affiliate agreement (banned claims, data handling, takedown rights, audit rights, indemnification).
- Build a partner-vetting framework: traffic source disclosure, banned-list screening, content review before approval.
- Pre-approve a creative library — copy, images, disclosures — that partners must use; ban free-form claims about products.
- Implement compliance monitoring: weekly review of partner placements, automated banned-claim keyword scanning.
- Schedule a quarterly compliance audit covering data flows, vendor BAA status, partner content, and consent logs.
Effective Monetisation Models in HealthTech Affiliate Marketing
HealthTech advertisers use various monetisation models depending on clinical complexity, consultation types, and product categories. Standard performance models include CPA, CPL, and hybrid structures combining fixed payouts with recurring commissions. Telemedicine subscriptions frequently rely on RevShare as it aligns incentives between advertisers and affiliates.
Monetisation in telehealth affiliate programs often prioritises quality over volume due to higher regulatory standards. Brands may implement tiered payment structures based on user retention, engagement, or verified consultations. Subscription-based HealthTech platforms typically track long-term performance metrics such as:
- Repeat telemedicine visits
- Medication refill frequency
- Continuity of digital care plans
A strategic approach to monetisation improves ROI while maintaining ethical marketing boundaries.
| Vertical | Typical CPL | Typical CPA | RevShare | Notes |
|---|---|---|---|---|
| Mental health / therapy apps | $8–$25 | $80–$200 | 20–35% | Subscription model favours RevShare; CPL useful for early-funnel partners |
| Telehealth GP / urgent care | $15–$45 | $60–$180 | 10–25% | Reimbursement-dependent; markets with strong insurance cover pay more |
| Rx delivery / online pharmacy | $10–$30 | $50–$150 | 5–15% | Margin-thin per script; volume model; strict on creative compliance |
| Weight loss / GLP-1 programs | $25–$80 | $150–$500 | 15–30% | Post-NextMed FTC action: payouts up but heavy compliance overhead |
| Chronic care management (CCM) | $30–$120 | $200–$800 | 20–40% | B2B2C; longer sales cycles; LTV justifies higher payouts |
| Dental / vision insurance | $8–$20 | $40–$120 | 10–20% | Insurance vertical; conversion-rate variance is high |
| DTC at-home test kits | n/a | $25–$80 (CPS 8–15%) | n/a | CPS dominates; one-off purchase, low LTV |
Footnote: Indicative ranges. Actual payouts depend on geo, channel quality, lead-qualification rules, and program maturity. Sources: Awin Healthcare Report, PartnerCentric benchmarks, IAB Health Vertical Survey, public network rate cards.
| Vertical pattern | Recommended model | Why |
|---|---|---|
| Subscription telehealth (mental health, CCM, monthly Rx refills) | RevShare (15–35%) | Recurring revenue + long LTV; partner shares upside |
| One-off DTC test kits, supplements | CPS (8–15%) | Single purchase; partner needs immediate margin signal |
| Lead-gen for clinics, insurance enrolment | CPL or CPA | Multi-touch sales cycle; brand controls qualification |
| Rx delivery / online pharmacy | Hybrid CPA + low RevShare | Thin per-script margin needs volume; RevShare incentivises retention |
| HCP-targeted programs (B2B intermediaries) | Flat CPA / CPM | HCP traffic is lower volume but higher value; clear contracted rates |
Vertical Playbooks
Mental health and therapy apps
Regulatory hotspots: HIPAA in the US; in 2023 the FTC fined BetterHelp $7.8M for sharing user health data with advertisers. Telehealth Consolidated Appropriations Act extended Medicare telehealth flexibilities through 2026.
Typical payout: RevShare 20–35% on subscription; or hybrid $15–$25 CPL + $80–$150 CPA on activation.
Best partner types: Wellness content publishers, therapist directories (Psychology Today), MD/RN influencers with mental health focus, employee benefits B2B.
Common pitfalls: Claims of curing anxiety or depression; behavioural retargeting on people who visited a depression-related page (privacy red flag); failure to disclose therapist credentialing scope by state.
Weight loss and GLP-1 programs
Regulatory hotspots: FDA off-label rules on GLP-1 drugs (Wegovy, Ozempic); FTC enforcement intensifying — see NextMed/Southern Health Solutions $150K settlement (July & December 2025) on false weight-loss claims and undisclosed pricing.
Typical payout: CPA $150–$500 on enrolment; RevShare 15–30% on subscription.
Best partner types: Compounded-medication review sites, MD influencers, comparison portals, women’s health publishers.
Common pitfalls: Weight-loss guarantee claims; before/after photos without consent and substantiation; price-only advertising that hides the cost of the medication itself.
Chronic care management
Regulatory hotspots: Medicare CCM and RPM reimbursement rules (CPT codes 99490, 99457); state-specific telehealth licensing; HIPAA for continuous patient monitoring data.
Typical payout: CPA $200–$800 per enrolled patient; RevShare 20–40% on platform revenue.
Best partner types: Disease-specific patient communities (diabetes, COPD, CHF), HCP networks, Medicare Advantage broker networks, caregiver content sites.
Common pitfalls: Targeting elderly patients without accessibility-compliant landing pages; claims of reducing hospital admissions without published outcomes data; partnering with brokers who don’t disclose CMS-required statements.
Prescription delivery and online pharmacy
Regulatory hotspots: DEA controlled-substance rules (Ryan Haight Act); state pharmacy boards; DSCSA (Drug Supply Chain Security Act); ANVISA in Brazil; restricted Rx advertising in Canada and EU.
Typical payout: CPA $50–$150; RevShare 5–15% (margin is thin per script).
Best partner types: Coupon and price-comparison sites (GoodRx-style), chronic care content publishers, employer-benefits intermediaries.
Common pitfalls: Implying same-day delivery of controlled substances; geo-targeting states where the brand isn’t licensed; affiliate-driven prescription form-fills that bypass clinical review.
HCP-targeted programs
Regulatory hotspots: Sunshine Act / Open Payments reporting; AdvaMed Code of Ethics; pharma-specific rules (PhRMA Code). Different rules apply to product promotion vs. medical education.
Typical payout: Flat CPA $50–$300 per verified HCP signup; or CPM $80–$250 on premium HCP networks.
Best partner types: Doximity, Sermo, Medscape, peer-reviewed journal sites, CME (continuing medical education) platforms.
Common pitfalls: Promotional content disguised as education; failure to file Open Payments reports for cash or in-kind value transfers above the threshold; non-verified HCP traffic from non-credentialed sources.
Choosing the Right Affiliate Partners
Selecting affiliate partners requires a rigorous evaluation process. Ideal partners include medical publishers, clinical information portals, licensed healthcare professionals, and specialised content creators. Affiliates must demonstrate credibility, relevant audience reach, and a history of compliant marketing.
Partnership evaluation criteria include:
- Medical content portals. Examples: Healthline, WebMD, Verywell Health. Volume: high. Quality: medium-high (well-targeted condition keywords). Risk: low; established compliance teams.
- HCP networks. Examples: Doximity, Sermo, Figure 1, Medscape. Volume: low. Quality: very high (clinicians targeting clinicians). Risk: low; usage gated to verified HCPs.
- Condition-specific patient communities. Examples: Reddit health subs (organic), PatientsLikeMe, Inspire. Volume: medium. Quality: high (motivated users). Risk: medium; content moderation and disclosure rigour vary.
- Comparison and review sites. Examples: Healthline Compare, Forbes Health, NerdWallet Health. Volume: medium. Quality: medium. Risk: medium; watch for outdated claims, hidden affiliate fees.
- Cashback and aggregator sites for telemedicine. Examples: RetailMeNot Health, Honey deals, Slickdeals. Volume: high. Quality: low to medium. Risk: high; price-driven users with low intent for ongoing care.
- MD/PA/RN influencers. Examples: Dr. Mike (YouTube), Dr. Karan Raj (TikTok), other credentialed creators. Volume: variable. Quality: very high. Risk: medium; disclosure compliance is the make-or-break.
- Corporate-wellness B2B intermediaries. Examples: Limeade, Virgin Pulse, Wellable. Volume: low but high LTV per account. Quality: very high. Risk: low; contracts, not affiliate links.
Working with high-quality partners strengthens brand reputation and improves user trust. Many brands also collaborate with medical affiliate networks that offer pre-vetted healthcare publishers and influencers for streamlined recruitment.
Duplicate consultations across partners. Same email/phone hash converted on multiple partners within hours. Catch with: cross-partner deduplication in your affiliate platform (native in IREV’s lead distribution module).
Geo-spoofed leads. Lead claims a US state but IP, device language, and timezone don’t match. Catch with: device fingerprinting (FingerprintJS), IP+timezone consistency checks.
Incentivised symptom checkers. Suspiciously high lead conversion from quiz-style funnels with low downstream booking rate. Catch with: completion-to-show-up ratio benchmarks per partner.
Fake HCP profile registrations. Spike in NPI numbers that don’t validate against the public NPPES registry. Catch with: real-time NPI lookup, license-verification APIs.
Bot-driven Rx form fills. Form completion in under 8 seconds, no scroll events, headless-browser signatures. Catch with: behavioural analytics, CAPTCHA v3 score thresholds, reCAPTCHA Enterprise.
Affiliate-on-affiliate co-registration. Lead arrives through one partner but cookies show six prior partner touches in 24h. Catch with: full attribution-path logging, suspicious-pattern alerts.
Pharmacy-shopper lead recycling. The same lead appearing across three competing Rx-delivery brands in the same week. Catch with: industry-wide blacklist services (LeadGenius, Anura), shared bad-actor lists.
Analytics & Performance Optimisation
Performance optimisation in HealthTech affiliate marketing requires privacy-centered tracking models and a robust analytical framework. Traditional attribution models may not fully apply due to cookie restrictions and regulatory limitations. Brands increasingly adopt server-side tracking, first-party analytics, and anonymised event-based measurement to comply with privacy standards.
| Model | How it works | Best for | Healthcare-specific caveat |
|---|---|---|---|
| Last-click | 100% credit to last touch | Quick MVP, simple programs | Heavily biased toward branded search and direct partners; under-credits upper-funnel content |
| Position-based (40-20-40) | 40% first touch, 20% middle, 40% last | Mid-maturity programs | Better than last-click for content-heavy verticals like mental health |
| Data-driven | ML-attributed credit per touchpoint | Mature programs with volume | Requires sufficient conversion data; works best in GA4 BigQuery export |
| Marketing Mix Modeling (MMM) | Top-down statistical model on aggregated data | Privacy-safe, multi-channel | Excellent for cookieless healthcare; revived by GDPR/HIPAA constraints |
| Incrementality testing | Geo or audience holdouts; measures lift vs. baseline | Validating partner value | Critical in regulated channels — last-click massively inflates branded-search affiliate value |
Key performance indicators include:
- Verified lead quality
- Conversion rate of telemedicine consultations
- Cost per qualified patient
- Lifetime value (LTV)
Optimisation strategies consist of A/B testing landing pages, adjusting traffic sources, and refining educational content. Brands must ensure all experiments respect regulatory constraints and avoid interventions that could compromise data integrity or user privacy.
| KPI | Healthy range (mature program) | Notes |
|---|---|---|
| Verified lead rate (lead → qualified) | 25–45% | Below 20% = lead quality issue or unclear qualification rules |
| Consultation completion rate | 55–75% | Telehealth GP; varies by booking-to-visit window |
| Conversion to paying customer | 8–18% | Higher in subscription telehealth; lower in DTC kits |
| Cost per qualified patient (CPQP) | $60–$220 | Depends on vertical and channel; chronic care can exceed $400 |
| Patient LTV / CAC ratio | 3x–5x | Below 2x = unsustainable; above 6x = under-investing in growth |
| Fraud rate (rejected leads) | <8% | Above 12% = a partner is gaming the system; investigate |
Real FDA/FTC Enforcement Examples
All cases are public; verify final outcomes against FTC.gov and FDA.gov before publishing.
| Case | What happened | Lesson for affiliates |
|---|---|---|
| FTC v. Southern Health Solutions (NextMed) — 2025 | The FTC settled charges against telehealth company NextMed for $150,000 in December 2025 over deceptive advertising of GLP-1 weight-loss programs. The complaint alleged hidden fees, undisclosed one-year commitments, fake testimonials, and unsubstantiated weight-loss claims. | Pricing transparency and review authenticity are now front-line enforcement priorities in telehealth. |
| FTC v. BetterHelp — 2023 | BetterHelp paid $7.8M to settle FTC charges that it shared consumer mental-health data with Facebook, Snapchat, and Pinterest for advertising despite promising not to. | Any retargeting or lookalike-audience push based on health-context data needs explicit, granular consent — and the consent flow itself must match the platform privacy promise. |
| FTC v. TruHeight — 2026 | In April 2026 the FTC took action against TruHeight for deceptive and unsubstantiated advertising of height-enhancement supplements marketed to children and teens. | Claims targeting minors face an even higher substantiation bar; affiliate creative for any pediatric-positioned health product needs separate compliance review. |
| FDA warning letters on supplements | The FDA routinely issues warning letters to supplement marketers — published on FDA.gov — for unapproved disease claims on websites, social media, and affiliate-influencer content. Common triggers: “cures arthritis,” “prevents cancer,” “treats diabetes” on landing pages or in influencer captions. | Train affiliate creators on banned verbs (“cure,” “treat,” “prevent,” “diagnose”) as a first-line filter. |
Conclusion
Affiliate marketing in HealthTech and telemedicine requires a structured, compliant approach that respects regulatory frameworks and user privacy. Brands must prioritise accuracy, ethical communication, and rigorous partner selection. Monetisation models should align with long-term patient engagement rather than short-term conversions. As digital healthcare continues expanding, organisations that build trustworthy and transparent affiliate ecosystems will secure sustainable competitive advantages.
FAQ
- Do I need a BAA with my affiliate network?
If the network handles any data that can identify a patient — emails matched to medical records, IP plus health-context, prescription details — yes. If the integration is strictly S2S with hashed identifiers and no clinical data reaches the network, a BAA may not be required, but document the data flow with privacy counsel either way. The deciding question is what the network can theoretically see, not what your team intends to send. - Can I run paid social ads to a telemedicine landing page?
Yes, but with constraints. Facebook and Google restrict health-condition targeting, especially for mental health, addiction, and prescription drugs. Disclosures must be in-creative, not buried in policy pages. Avoid retargeting based on visits to condition-specific pages — this is what landed BetterHelp a $7.8M FTC settlement in 2023. For Rx drugs in the US, follow FDA fair-balance rules in every creative. - Is GLP-1 / Ozempic affiliate marketing allowed?
Allowed, but tightly regulated and increasingly enforced. After the FTC’s NextMed settlement (December 2025, $150K), telehealth programs marketing GLP-1 weight-loss services must disclose total costs (medication, labs, consultation), avoid weight-loss guarantees, use verifiable testimonials only, and stay within FDA-approved indications. Off-label promotion (e.g., for purely cosmetic weight loss in non-eligible patients) is prohibited - Can I use AI-generated content for healthcare affiliate articles? Yes, but Google’s 2024–2025 medical-content updates penalise low-effort AI content. Best practice in 2026: AI as draft assistant, human medical reviewer named in byline, sources cited to primary references (HHS, FDA, peer-reviewed journals), and explicit ‘reviewed by [name, credentials]’ visible to readers. Pure AI output without review will lose ranking and risks FTC action if claims are unsubstantiated.
- What’s the difference between CPL, CPA, and RevShare for healthcare programs?
CPL (cost per lead) pays for an unqualified contact — typically $8–$80 in healthcare. CPA (cost per acquisition) pays only when the lead converts to a paying patient — $40–$800 depending on vertical. RevShare pays a percentage of patient revenue, typically 10–35%, and rewards ongoing subscription value. Subscription telehealth favours RevShare; one-off purchases (test kits, supplements) favour CPS or CPA; lead-gen for clinics with multi-touch sales cycles favours CPL.
Affiliate Event Playbook: 30-Day Plan Before, During and After a Conference
The majority of corporate conference budgets fail to generate a return because of an absent operational framework. Companies often treat events as passive opportunities for brand visibility, resulting in wasted capital and unquantifiable outcomes.
Affiliate World Dubai vs Europe vs Asia: Which Event Is Best for Your Growth Strategy?
The 2026 event landscape offers three distinct pillars within the Affiliate World series: Dubai, Europe, and Asia. Determining which venue aligns with your commercial objectives is a significant financial decision.